Urologie. Qualité de vie et sécurité : les nouvelles promesses

JMIG 2026

View at publisher
Authors: Maxence Emmanuel Reynard, Élisabeth Grobet-Jeandin, Olivier Laurent Windisch, Philippe Sèbe, Massimo Valerio A
DOI: 10.53738/revmed.2026.22.945.47974
Cited by: 0

Abstract

Oncologic urology continues to evolve, driven by innovations that share a common goal: improving clinical outcomes while reducing the risks and burden for patients. In 2025, several randomized studies supported emerging practices by providing the level of evidence that was still lacking, namely regarding transperineal prostate biopsy under local anesthesia, streamlined bladder cancer surveillance using urinary biomarkers, and nerve-sparing robot-assisted prostatectomy guided by intraoperative frozen section analysis. These advances confirm a strong trend in urology toward greater precision and pragmatism, as well as a sustained focus on patient experience and quality of life.

Fields of Study & Subjects

Prostate Cancer Diagnosis and Treatment Prostate Cancer Treatment and Research Bladder and Urothelial Cancer Treatments

Publication details

Journal / source
JMIG
Volume
22
Issue
945
Pages
79–82
Publication date
1 January 2026
Language
EN